We recommend to visit
Background. Dialysis patients are known to have an increased risk of total and cardiovascular mortality. Previously we described that vascular calcification (VC) is an independent predictor of novel non-fatal cardiovascular events in haemodialysis (HD) patients. Fibroblast growth factor-23 (FGF 23) and Matrix Gla protein (MGP) are known to be important contributors for VC and mortality in HD patients. There have been studies analysing the associations between FGF 23, MGP and cardiovascular diseases, but not in the special cohort of maintenance HD patients.
EN
